Copyright © Inderes 2011 - present. All rights reserved.

Nanoform Finland

0.69 EUR

-1.57 %

3,695 following

NANOFH

First North Finland

Medical Equipment & Services

Health Care

-1.57 %
-18.87 %
-41.30 %
-27.58 %
-21.82 %
-34.10 %
-67.24 %
-91.35 %
-86.38 %

Nanoform Finland operates in the medical technology sector. The company specializes in research and development of nanoparticle technology used to create nanoparticles in pharmaceuticals. The technology is used as a complement in the production process and is used for the treatment of diseases such as ALS and Alzheimer's. Customers consist of players in the global pharmaceutical industry, with the largest operations in the Nordic market. Nanoform Finland is headquartered in Helsinki.

Read more
Market cap
58.94M EUR
Turnover
61.09K EUR
Revenue
3.55M
EBIT %
-521.09 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
14/4
2026

General meeting '26

19/5
2026

Interim report Q1'26

20/8
2026

Interim report Q2'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
This company is tricky to evaluate in the short term, as such a large portion of its potential depends on projects conducted with customers, about which not much can be disclosed externally yet for understandable reasons. If information were available regarding, for example, the ...
3/1/2026, 5:39 PM
by jerej
16
I plotted these Handelsbanken holdings. Sales have now averaged 500k per month. If Handelsbanken intends to sell off its entire position, and those sales continue at the same pace as they have so far, the selling pressure will likely continue until roughly next summer. There hasn...
3/4/2026, 1:39 PM
by jerej
10
I listened to that webcast yesterday. I’ll share my thoughts over the weekend. According to the CEO, the cash burn estimate for this year (approx. -€10M) does not include milestone payments. Management likely doesn’t want to forecast them for this year as their timing is probably...
2/27/2026, 4:08 PM
by jerej
8
This sums up the case quite well at the moment. Personally, I’m still quite optimistic about this. At least so far, everything seems to be progressing, though maybe two years behind what was originally thought. Perhaps many others have invested here with a shorter-term view, but ...
3/2/2026, 1:30 PM
by jerej
6
My guess is that partnering negotiations are still ongoing for some reason. These haven’t been updated recently, but here is the 2025 H1 update on the situation at that time. At that stage, the only market for which an agreement had already been signed was Germany. edit: I dug a ...
11 hours ago
by jerej
5
260,000 shares decreased in February at Handelsbanken. -30,000 shares for HÆGGSTRÖM ALBERT ALEXANDER. I wonder if there were some transfers since no notification has been issued.
3/7/2026, 1:00 AM
by Latupuikko
3
Thank you Jerej for your comprehensive and thoughtfully reflective response. I need to read this carefully at a suitable moment, and also listen to the webcast while following the slides. There is information there, after all. The situation would be so much nicer if the cash position...
3/1/2026, 9:39 PM
by JusaVaan
3
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.